THRIVE: Culturally AdapTed Harm Reduction Intervention

NACompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

April 2, 2025

Primary Completion Date

June 20, 2025

Study Completion Date

June 20, 2025

Conditions
Opioid UseStimulant Use
Interventions
BEHAVIORAL

harm reduction intervention

Each participant will complete a pre-test at Study Visit 1 prior to the intervention, participate in the intervention, then complete a post-test. After the intervention, participants will participate in a recorded focus group. Participants will be offered FTS, Narcan, first aid supplies at the study visit.

Trial Locations (3)

40203

Louisville Central Community Center, Louisville

45219

Urban Minority Alcoholism and Drug Abuse Outreach Program (UMADAOP) of Cincinnati, Cincinnati

45221

University of Cincinnati, Cincinnati

All Listed Sponsors
collaborator

University of Cincinnati

OTHER

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

collaborator

National Center for Research Resources (NCRR)

NIH

lead

Brittany Miller-Roenigk

OTHER

NCT06609278 - THRIVE: Culturally AdapTed Harm Reduction Intervention | Biotech Hunter | Biotech Hunter